期刊文献+

大肠埃希菌临床株的耐药性调查 被引量:9

Drug-resistance of Escherichia coli:An Investigation of Its Clinical Isolates
原文传递
导出
摘要 目的探讨基层医院大肠埃希菌(ECO)的耐药现状,为临床医师合理使用抗菌药物提供试验依据。方法大肠埃希菌分离鉴定按《全国临床检验操作规程》进行,用CLSI推荐的K-B法进行药敏试验和评价结果。结果医院临床分离的大肠埃希菌对14种常用抗菌药物表现出不同的耐药性,其中,以氨苄西林耐药率最高,达95.0%,而碳青酶烯类抗菌药物亚胺培南敏感率为100.0%;产超广谱β-内酰胺酶(ESBLs)大肠埃希菌的检出率为33.3%。结论基层医院大肠埃希菌的耐药问题也比较严重,应重视耐药菌的监测与控制工作。 OBJECTIVE To investigate the drug-resistance status in clinical isolates of Escherichia coli(ECO) in grass-roots hospital to provide the evidence for reasonable use of antibiotics.METHODS ECO isolates were isolated and identified according to the National Clinical Laboratory Operation Rules.Drug resistance profile was analyzed by K-B method,as recommended by the CLSI.RESULTS The different drug-resistance to 14 commonly used antibiotics had occurred in clinical isolates of ECO.The resistance rate to ampicillin was the highest,accounted for 95.0%.There was not any strain that was resistant to carbopenems such as imipenem.The detection rate of extended spectrum β-lactamases(ESBLs) producing ECO was 33.3%.CONCLUSION Drug-resistance status of ECO in grass-roots hosptitals is very serious.We should attach importance to monitoring and controlling the spread and prevalence of the drug-resistant bacteria.
作者 黄智明
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2010年第17期2680-2681,共2页 Chinese Journal of Nosocomiology
关键词 大肠埃希菌 临床菌株 耐药性 超广谱Β-内酰胺酶 Escherichia coli Clinical isolates Drug-resistance Extended spectrum β-lactamases
  • 相关文献

参考文献6

二级参考文献43

共引文献138

同被引文献72

  • 1文细毛,任南,吴安华,徐秀华,李洁.全国医院感染监控网老年患者医院感染病原菌及其耐药特征分析[J].中华医院感染学杂志,2005,15(12):1346-1348. 被引量:125
  • 2闫改荣.患者医院内尿路感染相关因素分析及预防对策[J].中医药管理杂志,2007,15(4):273-274. 被引量:5
  • 3中华人民共和国卫生部,医院感染诊断标准[s].北京:中华人民共和国卫生部,2001.
  • 4中华人民共和国卫生部.医院感染诊断标准[S].北京:中华人民共和国卫生部,2001.1-35.
  • 5Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing[S]. 18th ed. Ap- proved standard M2-A9 (M100-S18). CLSI, 2008. 116--8.
  • 6Philippon A, Arlet G, Jacoby GA. Plasmid determined AmpC type betalactamases[J]. Antimicrob Agents Chemother, 2002, 45 (4): 1--11.
  • 7胡必杰,宗志勇,顾克菊.多重耐药菌感染控制最佳实践[M].上海:上海科学技术出版社,2012:108.
  • 8Maragakis LL, Perl TM. Acinetobter baumnii : epidemiolog, timicmbial resistance, and treatment options [J]. Clin Infect Dis, 2008,46(8) : 1254-1263.
  • 9Hong F, Ferda A, Goran H, et al. Molecularepi-demiology of extended-spectrum-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006 [J]. J of Clinical Microbiology, 2008,46 (2) : 707-712.
  • 10Bearman GM,Marra AR,Sessler CN,et al. A controlled trial of universal gloving versus contact precautions for preventing the transmission of multidrug-resistant organ- isms [J]. Am J Infec Control,2007,35(10):650-655.

引证文献9

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部